Skip to Main Content

Author Details

Hartland W Jackson
Lunenfeld-Tanenbaum Research Institute
2010
24
14
PMIDPaper TitleJournal TitlePublished Year
36308030An Engineered Paper-Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell Phenotype.Adv Healthc Mater2023
37670013Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.Nat Commun2023
37258521In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.Nat Commun2023
36921599Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers.Cell Rep Med2023
36108220Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer.Cancer Discov2022
35492239Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.Cell Rep Med2022
36776528Genetic perturbations go spatial.Cell Genom2022
34196309Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.J Clin Invest2021
31959985The single-cell pathology landscape of breast cancer.Nature2020
29289569Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry.Cell Syst2018
29966523Correction to: Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.J Transl Med2018
30222135Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.J Clin Invest2018
29698648Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry.Cell Syst2018
29739401Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.J Transl Med2018
27932800TIMPs: versatile extracellular regulators in cancer.Nat Rev Cancer2017
28783155histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data.Nat Methods2017
27314104Tumor suppression by stromal TIMPs.Mol Cell Oncol2016
25807548Timp3 deficient mice show resistance to developing breast cancer.PLoS One2015
28447939A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland.Stem Cell Reports2015
26095608RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1.Stem Cell Reports2015
25706237Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice.Nat Cell Biol2015
25150980Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.Nat Cell Biol2014
22053204TIMP3 regulates mammary epithelial apoptosis with immune cell recruitment through differential TNF dependence.PLoS One2011
20445538Progesterone induces adult mammary stem cell expansion.Nature2010
  • 1 - 24 of 24

Recommended Authors

McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2016
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 0
University of Trento
Career Start Year 2012
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 1
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 1
University of Cambridge
Career Start Year 2004
Number of shared co-authors 11
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Vanderbilt University School of Medicine
Career Start Year 2003
Number of shared co-authors 3
University of California berkeley
Career Start Year 2003
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2002
Number of shared co-authors 1
Oncology R&D
Career Start Year 2000
Number of shared co-authors 0
Monash University
Career Start Year 2000
Number of shared co-authors 4
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 2
European Cancer Stem Cell Research Institute, Cardiff University
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1996
Number of shared co-authors 1
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 1
University Health Network
Career Start Year 1994
Number of shared co-authors 12
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 4
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Oncode Institute, Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 6

Collaborators

Princess Margaret Cancer Centre, University Health Network
Co-authored papers 11
University of Zurich
Co-authored papers 8
Princess Margaret Cancer Centre/University Health Network
Co-authored papers 6
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Co-authored papers 3
Princess Margaret Cancer Centre
Co-authored papers 3
Ontario Tech University
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University of Toronto
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
IRIC - University of Montreal
Co-authored papers 2
Schroeder Arthritis Institute
Co-authored papers 2
University of Toronto
Co-authored papers 2
Schroeder Arthritis Institute
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Beihua University
Co-authored papers 2
BC Children's Hospital Research Institute
Co-authored papers 2
University Hospital Zurich
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of Zurich
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Max Planck Institute of Biochemistry
Co-authored papers 1
Center for Coregulator Research, Baylor College of Medicine
Co-authored papers 1
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
SickKids Research Institute
Co-authored papers 1